TipRanks
Go Ultimate55% OFF

Ingmar Bruns Insider Profile

11 Followers

Ingmar Bruns, CMO at Zentalis Pharmaceuticals, holds 43.06K shares in Zentalis Pharmaceuticals (Ticker: ZNTL).

Ingmar Bruns's Trading History

ZNTL
Zentalis Pharmaceuticals
Oct 01, 2026CMOUninformative Buy21.20K$84.40K
ZNTL
Insider Shares: 43.06K (0.05%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 01, 2026Uninformative Buy$21.20K9,727$2.18―
Feb 10, 2026Informative Sell$7.97K3,297$2.41+18.30%
Feb 12, 2025Informative Buy$45.60K20,000$2.28+11.10%
Feb 05, 2025Uninformative Buy$0.0016,629$0.00―

You May Also Like

Ingmar Bruns insider profile FAQ

What is the percentage of profitable transactions made by Ingmar Bruns?
The percentage of profitable transactions made by Ingmar Bruns is 100%.
What is the average return per transaction made by Ingmar Bruns?
The average return per transaction made by Ingmar Bruns is 14.70%.
What stocks does Ingmar Bruns hold?
Ingmar Bruns holds: ZNTL stocks.
What was Ingmar Bruns’s latest transaction?
Ingmar Bruns’s latest transaction was an Uninformative Buy of $21.20K.
What was Ingmar Bruns's most profitable transaction?
Ingmar Bruns’s most profitable transaction was an Informative Sell of ZNTL stock on February 10, 2026. The return on the trade was 18.30%.
What is Ingmar Bruns's role in Zentalis Pharmaceuticals?
Ingmar Bruns's role in Zentalis Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.